A DOAR Research Center report commissioned by WIT reveals important findings from a new survey assessing attitudes toward pharmaceutical companies by potential jurors.
A survey commissioned by WIT Legal reports on jurors' attitudes toward pharmaceutical companies and several issues that are suspected of creating juror bias. The survey targeted two venues where ANDA litigation is particularly prevalent – the District of New Jersey and the District of Delaware, and specifically measured the following:
- General perception of the pharmaceutical industry
- Attitudes toward brand drug companies and generic drug companies
- Opinions of U.S., European, Chinese, and Indian pharmaceutical companies
- Experiences with and concerns about prescription drug prices
- If and how experiences with COVID and the development of COVID-19 vaccines played a factor in personal beliefs regarding pharma companies
- Demographic analysis of juror attitudes (e.g. race, political affiliation, age, education)
Enter your information below to receive a download link featuring insights regarding jury selection, your trial strategy, and the types of experts who can support your case.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.